Ranbaxy Of India To Market Drugs Of Parent Daiichi Sankyo In Mexico
This article was originally published in PharmAsia News
Executive Summary
India's Ranbaxy Laboratories plans to market the drugs of its parent company, Japan's Daiichi Sankyo, in Mexico